Immunodiagnostic Reagent Market to Reach USD 14.83 Billion by 2026 | Reports And Data

Immunodiagnostic Reagent Market Size – USD 5.45 billion in 2018, Market Growth - CAGR of 13.2%, Immunodiagnostic Reagent Industry Trends – Increase in the technological advancement of the immunodiagnostic reagent industry

Rise in the adoption of immunoassay analyzers, increase in availability of reagents across different research settings and growth in R&D investments are the factors driving the growth of the immunodiagnostic reagent market

NEW YORK, Oct. 23, 2019 /PRNewswire/ -- According to the recent analysis of Reports and Data, the global immunodiagnostic reagent market is expected to reach USD 14.83 billion by year 2026, in terms of value at a CAGR of 13.2% from 2019-2026. The rise in the incidence of diseases such as HIV, respiratory, cancer, and others is likely to drive the growth of the global immunodiagnostic reagent market. Moreover, growing geriatric population and the surge in need to develop therapeutic treatments to treat chronic diseases is boosting the R&D infrastructure. The rise in R&D investments globally along with increase in awareness and availability of different immunodiagnostics reagents are expected to drive the global immunodiagnostic reagent market during the forecast period. However high costs associated with immunodiagnostics reagents is expected to hamper the market growth to a certain extent. Conversely, untapped potential of emerging economies is anticipated to provide lucrative growth opportunities to the players in the market in the forecast period.

Different biomolecules such as proteins act as immunodiagnostic reagent agents to execute immunodiagnostic reactions. After clinical laboratories and hospitals, the pharmaceutical and biotechnology industries are the traditional strongholds of the immunodiagnostic reagent market. Immunodiagnostic Reagent kits are widely used by druggists to monitor drug delivery and the effect of the drugs administered in the system.

Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/2110

Key strategic initiatives such as product launches by companies and approval for new immunodiagnostic reagent products and services is also expected to substantially foster the growth rate of the global market. For instance, OPKO Health Inc. had an approval from the U.S. Food and Drug Administration in 2017 to conduct a full prostate-specific antigen test with immunoassay analyzer. Rising adoption of immunoassay analyzers will facilitate cost-effectiveness and reduce the barriers to conduct efficient diagnostic procedures. This is one of the major drivers of the immunodiagnostic reagent market.

North America is occupied the largest market share in the global immunodiagnostic reagent market in 2018. Rise in the investment towards research and development to find different novel therapeutics and various diagnosis methods for the treatment of serious diseases is one of the major factors fueling to the growth of the immunodiagnostic reagent market in North America. Moreover, increase in government support towards these initiatives is also expected to supplement the global immunodiagnostic reagents market.

By region, the Asia Pacific market is projected to grow at the highest rate throughout the forecast period. Increase in the technological advancement in the region along with development of new research facilities in the emerging markets such as China and India are a key factor influencing immunodiagnostic reagent market growth in this region.

Further key findings from the report suggest

• Trainings that employ immunodiagnostics reagents are routinely provided in academic and research centers and medical colleges in the form of internships. The increased use of these immunodiagnostics consumables has surged the demand for these products worldwide, thereby boosting the immunodiagnostic reagents market.
• ELISA reagent market in Europe occupied a significant share in 2018. The Europe market for ELISA reagents is projected to grow at a CAGR of 14.2% during the forecast period.
• Asia Pacific Market is expected to grow at the highest CAGR of 16.8% during the forecast period. Increasing disposable incomes and healthcare facilities in developing nations such as China, and India are likely to propel the market growth in the analysis period.
• By application, the cardiac biomarker segment is growing gradually and is expected to reach USD 2.67 billion by 2026. This can be attributed to the increase in dire need of. novel therapeutic treatments for cardiovascular disease treatment.
• In 2018, the hospitals segment in North America witnessed significant growth as the tests and the reagents are more prominently used in North America, more prominently in the U.S.
• Key participants in the immunodiagnostics reagents market include – Abbott Laboratories, Immunodiagnostic Reagent Systems Holdings Plc (IDS), DiaSorin S.p.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Siemens AG, Sysmex Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., OPKO Health Inc., Bio-Rad Laboratories, Inc., and Arkray, Inc.

To identify the key trends in the industry, click on the link below:   https://www.reportsanddata.com/report-detail/immunodiagnostic-reagent-market

Segments covered in the report:

For the purpose of this report, Reports and Data has segmented the global immunodiagnostic reagent market on the basis of by reagent, by application, by end user and region:                    

By Reagent (Revenue, USD Million; 2016–2026)

• Enzyme-linked Immunosorbent Assay (ELISA) Reagents and Kits
• Rapid Test Reagents and Kits
• Enzyme-linked Immunospot ELISPOT Reagents and Kits
• Western Blot Reagents and Kits
• Other Reagents & Kits

By Application (Revenue, USD Million; 2016–2026)

• Infectious Diseases
• Hepatitis & retrovirus
• Oncology & endocrinology
• Bone & mineral
• Autoimmunity
• Cardiac biomarker
• Other Applications

By End User (Revenue, USD Million; 2016–2026)

• Clinical Laboratories
• Hospitals
• Academic & Research Centers
• Pharmaceutical & Biotechnology Industry
• Other End Users

Order Now: https://www.reportsanddata.com/checkout-form/2110

By Region (Revenue, USD Million; 2016–2026)

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Spain
• Italy
• Rest of the Europe
• Asia Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Middle East & Africa
• Latin America
• Brazil

Browse more similar reports on Pharmaceutical category by Reports And Data

Antiviral Drugs Market - https://www.reportsanddata.com/report-detail/antiviral-drugs-market

Folinic Acid Market - https://www.reportsanddata.com/report-detail/folinic-acid-market

Crizotinib Market - https://www.reportsanddata.com/report-detail/crizotinib-market

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

Logo: https://mma.prnewswire.com/media/1009077/Reports_And_Data_Logo.jpg